Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.

Cancer letters - 1 Aug 2010

Hodgkinson Victoria C, Eagle Gina L, Drew Philip J, Lind Michael J, Cawkwell Lynn

Abstract excerpt

This review describes and discusses the advantages and limitations of proteomic approaches in the identification of biomarkers associated with chemotherapy resistance. Both gel-based (two-dimensional polyacrylamide gel electrophoresis) and gel-free (shotgun and quantitative) mass spectrometry app...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Drug Resistance, Neoplasm
Share to Electrophoresis, Polyacrylamide Gel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Protein Processing, Post-Translational

Share to Proteomics

Share to Spectrometry, Mass, Electrospray Ionization

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source

Identifiers

PMID: 20176436
DOI: 10.1016/j.canlet.2010.01.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20176436-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.PMID 20176436Read ↗

Biomarkers and Multiple Drug Resistance in Breast CancerSemantic proximity Read ↗

Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics AnalysisSemantic proximity Read ↗

Breast cancer proteomics: a review for cliniciansSemantic proximity Read ↗

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast CancerSemantic proximity Read ↗

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read ↗

Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and TreatmentSemantic proximity Read ↗

Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysisSemantic proximity Read ↗

Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomicsSemantic proximity Read ↗

Retrospective Proteomic Screening of 100 Breast Cancer TissuesSemantic proximity Read ↗

Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.Semantic proximity Read ↗

BC-Predict Database: A Curated Resource of Experimentally Validated Markers in Multidrug Resistance in Breast CancerSemantic proximity Read ↗

Multicenter reverse-phase protein array data integrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.